insights fall 2012 magazine

Download Insights Fall 2012 Magazine

Post on 24-Mar-2016




1 download

Embed Size (px)


Insights Fall 2012 Magazine


  • Canadas voice for biotechnology / Le porte-parole canadien de la biotechnologie

    Sanofi Pasteur Canada: 100 years of discovery / Sanofi Pasteur Canada : 100 ans de dcouvertes page 9PM


    fall / automne

    Neal Carter on his companys fresh innovation, Arctic Apples / Neal Carter discute la pomme Arctic, le fruit de linnovation de sa socit page 57

    BELIEVE IN BIOTECHCanadas biotech industry is positioned to reinvent and transform our lives and economy

    La BIOTECHNOLOgIE IL fauT y CrOIrELe secteur canadien de la biotechnologie est en mesure de rinventer et de transformer nos vies et notre conomie

  • BIOTECanada fall / automne 2012 | 3


    04 MessAge froM the President And Ceo by Andrew Casey

    06 MessAge du Prsident et Chef de LA direCtionpar Andrew Casey

    dePArtMents / seCtions

    09 heALth +Sanofi Pasteur Canada: Celebrating 100 years of discovery by J. Mark Lievonen

    sAnt +Sanofi Pasteur Canada : 100 ans de dcouvertes clbrerpar J. Mark Lievonen

    28 heALth +The spinal cord injury landscape in Canada: Today and beyondby Bill Barrable

    sAnt +Le point sur la situation du traumatisme de la moelle pinire au canada et sur les perspectives davenirpar Bill Barrable

    43 LegAL MAtters Navigating the Patent Prosecution Highway (PPH) in Canadaby Beverley Moore, Jennifer Raoul and

    Mhairi Skinner

    questions de droit Naviguer sur lAutoroute du traitement des demandes de brevet (ATDB) au Canadapar Beverley Moore, Jennifer Raoul et

    Mhairi Skinner

    57 AgriCuLturAL BioteCh Market fresh: Arctic Apples set to bring biotech to your grocery storeby Nadine Lunt

    BioteChnoLogie AgriCoLe La pomme Arctic : Le fruit de la biotechnologie bientt dans votre supermarch! par Nadine Lunt

    61 heALth +Canada can drive prosperity through innovative partnershipsby Alison Symington

    sAnt +Des partenariats innovants pro-pulsent la croissance conomiquepar Alison Symington

    fall / automne 2012

    Publisher / diteurgordongroupTel./tl. : (613) 234-8468

    Editor / rdactrice en chefNadine Lunt

    Translation / TraductionSophie Campbell

    art direction and design / Direction artistique et conceptionLeslie MilesRen DickAlina Oliveira

    Contributing writers / CollaborateursBill BarrableJ. Mark LievonenNadine LuntBeverley MooreKira PejemskySamantha PereiraJennifer RaoulStephen SampsonMhairi SkinnerAlison Symington

    Editorial board / Comit de rdactionJoanne HarackTim Lougheed

    for additional copies of insights / Pour obtenir dautres exemplaires de insightsTel./tl. : 613-230-5585Email/courriel :

    advertising / PublicitTel./tl. : 613-288-5363Email/courriel :

    advertising sales direction / Directeur commercialKirill Kornilov

    Printing / ImpressionDollco Printing

    Return undeliverable Canadian addresses to: / Retourner toute correspondance ne pouvant tre livre au Canada : BIOTECanada 1, rue Nicholas Street, Suite / bureau 600 Ottawa, Ontario Canada K1N 7B7

    Canada Post Publication Agreement number / numro de convention de publication, Postes Canada : 40064931 issn 1705-3315

    Contributions are welcome. Contact the editor at: / Les contributions sont invites. Contactez la rdactrice en chef :

    2012 BIOTECanada insights. Any errors, omissions or opinions found in this magazine should not be attributed to the publisher. The authors, the publisher and the collaborating organizations will not assume any responsibility for commercial loss due to business decisions made based on the information contained in this magazine. No part of this publication may be reproduced, reprinted, stored in a retrieval system or transmitted in part or whole, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written consent of the publisher.

    2012 BIOTECanada insights. Aucune erreur ou omission dcele dans ce magazine ou aucune opinion qui y est exprime ne doit tre impute lditeur. Les auteurs, lditeur et les organismes cooprants nassument aucune responsabilit lgard de pertes y commerciales pouvant dcouler de dcisions daffaires prises la lumire des renseignements contenus dans ce magazine. Il est interdit de reproduire, de rimprimer, demmagasiner dans un systme de recherche documentaire ou de transmettre cette publication en tout ou en partie, sous quelque forme ou par quelque moyen que ce soit (lectronique, mcanique, photocopie, enregistrement ou autre), sans avoir obtenu au pralable le consentement crit de lditeur.

    feAtures / ArtiCLes

    17 reflections on Bio 2012by Stephen Sampson

    rflexions sur le congrs Bio 2012par Stephen Sampson

    23 gold Leaf Awards recognize the best of Canadian biotech by Kira Pejemsky

    Les feuilles dor rendent

    hommage la crme des biotechnologies canadiennespar Kira Pejemsky

    33 Canadian science brings patients hope

    La science Canadienne offre de lespoir aux patients

    36 Creative Canadian science: National Biotechnology Week overview by Nadine Lunt

    Crativit des sciences au Canada : Aperu de la Semaine nationale des biotechnologiespar Nadine Lunt

    46 the current state of subsequent entry Biologics in Canada: Overview of the National Summit on Subsequent Entry Biologics Chairmans Report

    La situation actuelle des produits biologiques ultrieurs au Canada : survol du Rapport du prsident au sujet du sommet national sur les produits biologiques ultrieurs

    52 Combating treatment delays and overuse of antibiotics with new diagnostic device by Samantha Pereira

    un nouvel outil de diagnostic permet de rduire les dlais de traitement et lutilisation abusive dantibiotiques par Samantha Pereira

  • 4 | BIOTECanada

    since joining BioteCanada earlier

    this year, i have been struck by the

    people in this industry and the

    passion they exude for their lifes

    work. As I travel across Canada to meet our members and industry leaders, I find in them a spark and a determina-tion that is contagious. Canadas researchers and entrepreneurs are the individual links in the strong network of companies and institutions working to ensure we stay among the worlds best in biotechnology.

    From improved resource management to streamlined manufacturing technolo-gies, from new medicines to healthier foods, from renewable energy sources to cleaner chemical production, biotech-nology is driving innovation within all elements of the Canadian economy. We are now at a point where biotechnology is an essential component that will facilitate the reinvention of numerous industries, ensuring Canadas long-term competitiveness while creating employ-ment opportunities for our best and brightest. This new reality offers a distribution of economic opportunities that extends across the country.

    In April 2012, the Obama administration launched the National Bio-economy Blueprint, a strategy to increase research capacity, cut regulatory hurdles and identify areas where the U.S. can be competitive. Similarly, the European Commission recently adopted a bio-economy strategy with a clear focus on innovation for environmental sustainability. Clearly, Canada is facing significant international pressure to keep pace. If we are to remain competitive in this

    regard, industry and governments must meet and exceed what other countries are doing to spur the commercialization of their biotech and life sciences technologies.

    Biotechnology must remain at the leading edge of innovation, but it will not happen in isolation. Canada has made significant progress in securing important building blocks for our growing bio-economy. But the need for coordinated action from all parties remains. By working together, industry and governments can put in place a competitive market framework that will attract research investment and deliver the rewards of commercialization.

    While much has been done to support the growth of Canadas biotech industry, more still can be done to foster a vibrant, thriving sector. Given the diverse nature of the industry, it is not entirely surprising that government policy has become fragmented in response. Depending on the process or the product, biotech companies can be subject to a number of overlapping and duplicative policy regimes. At the federal level alone, the industry falls under the mandates of no fewer than six departments, including Industry, Health, Finance, Agriculture and Agri-Food, Environment and Natural Resources. Understandably, this can lead to duplication and confusion for both industry and government, which threatens to compound itself as the industry continues to grow and extend its reach further into the economy. With so many sectors depending on biotech, it is imperative that industry and government work together to

    develop a strategic and coordinated public policy framework in support of the industry, its products and its investments.

    I hope you enjoy this edition of insights and I welcome your feedback.

    MessAge froM the President And Ceo by Andrew Casey

    By working together,

    industry and

    governments can put

    in place a competitive

    market framework that

    will attract research

    investment and

    deliver the rewards

    of commercialization.

  • BIOTECanada fall / automne 2012 | 5

  • 6 | BIOTECanada

    depuis que je suis entr chez

    BioteCanada plus tt cette anne,

    je suis frapp par la passion

    quaffichent les gens de cette

    industrie pour leur travail quotidien.

    Dans mes voyages travers le Canada la rencontre de nos membres et des chefs de file de lindustrie, je constate dans lil de ces personnes une contagieu